REMMO 40

Description

REMMO 40 mg IM/IV Injection

Indications
Adults (from the age of 18 years)

Gastroesophageal reflux disease (GERD)
Non-erosive reflux disease (NERD) (i.e. heartburn and regurgitation)
Maintenance treatment of NERD (i.e. heartburn and regurgitation)
Reflux esophagitis or erosive esophagitis

Pharmacology
The proton pump inhibitor Esomeprazole inhibits gastric acid by blocking the hydrogen-potassium adenosine triphosphatase enzyme system (the proton pump) of the gastric parietal cell. Proton pump inhibitors are effective for short-term treatment of gastric and duodenal ulcers. Esomeprazole is also used in the prevention and treatment of NSAID associated gastric ulcers.

Dosage
Adults (from the age of 18 years)-
Gastroesophageal reflux disease (GERD):
Non-erosive reflux disease (NERD) (i.e. heartburn and regurgitation): 20 mg Once daily for 24 weeks
Maintenance treatment of NERD (i.e. heartburn and regurgitation): 20 mg Once daily
Reflux esophagitis or erosive esophagitis: 20 mg or 40 mg Once daily for 4-8 weeks
Maintenance therapy of healing of reflux esophagitis: 20 mg Once daily
Healing of NSAID associated gastric ulcers: 20 mg Once daily for 4-8 weeks

Risk reduction of NSAID associated gastric ulcers: 20 mg Once daily

Zollinger-Ellison Syndrome: 40 mg Twice daily

H. pylori eradication (Esomeprazole with amoxicillin 1000 mg and clarithromycin 500 mg): 20 mg tab. twice daily for 7 days or 40 mg cap. once daily for 10 days

Pediatrics (12 to 17 years)-
Gastroesophageal reflux disease (GERD):
Non-erosive reflux disease (NERD) (i.e. heartburn and regurgitation): 20 mg Once daily for 2-4 weeks
Reflux esophagitis or erosive esophagitis: 20 mg or 40 mg Once daily for 4-8 weeks.